Pf

inding chemical information in the Pfizer research environment: SciFinder



By Pamela J. Scott

The NEW Pfizer



The best get better!

• • • •

Global research facilities Scientific staff of over 12,000 Industry’s largest R&D budget for 2000: $4.7 billion 131 compounds in development

http://www.pfizer.com

SciFinder



: Historical Overview



Fall 1995: Pilot group of 25 each in Groton & UK



1/1996: 100 users



1/1998: 831 users

–

limited access to SSM



1/1999: 1001 users

–

open access to SSM



1/2000: 1419 users



1Qtr 2000:

–

links to full-text

–

links to in-house Doc Delivery

Where We Are In 2000



~1,500 SciFinder users



adding 1-5 per week



Countries: Japan, England and United States



Beta testing Y2000 release (in progress)



Coordinating efforts and project planning with new Pfizer sites, looking for best practices

Administration Issues



HelpDesk responsibilities:



Daily registration of new users



Also software installations & upgrades



My responsibilities:



Training & education



Communication



Alpha, beta tests



Schedule upgrades



Overall project management

New User Training



~Once a week



1-8 people per class



Topics covered:



Support links & online tutorials



Preferences



TOC



CAS database organization & coverage



Searching for compounds



Keyword searching



Setting up Alerts



Full-text links & Document Delivery

Advanced Training



Every 6 months



Sessions include:



SSM



Reaction searching



Managing your Alerts

Other Education



Via email notification:



New tools



Tips & tricks



Deleting obsolete Alerts



etc.

Web Support Page



To provide overview information, help & assistance when I’m not available.



Streamline the Registration process.



Covers:



Scope of SciFinder

 

Registration form “Forgot your password” form



Contact information (me, CAS Helpdesk)



E-manuals



Links to CAS online tutorials

How SciFinder Is Used

6% 6% 6% 6% 1%1% 10% 23% 41%

Alerts Topics Exp Author Exp Structure Exp Substance ID Exp SSM Exp RXN Exp Browse TOC Doc. ID Exp

More Usage Info



Who is using it?



Primarily Discovery



small numbers for Development



New surge in Biologists sign-up

–

also Biochemists, Molecular scientists, protein chemists

More Usage Info



Global trends:



same in UK



similar in Japan



Impact on other chemical information products:



Beilstein/CrossFire



Aurigin



MicroPatent



others

New Links To Full-text



Critical link to full-text on an expanding campus



Exploits subscriptions to e-journals



If not accessible, quick link to in-house ordering system

Impact On Document Delivery



35% of Doc Delivery requests were from SciFinder users, and looked like this:

Tombari, D. G.; Moglioni, A. G.; Iglesias, G. Y. Moltrasio. New pterosin precursor hydrindacenes. Synth. Commun. (2000), 30(12), 2113-2120. CODEN: SYNCAV ISSN:0039-7911. AN 2000:353406 CAPLUS Leclerc, V.; Beaurain, N.; Depreux, P.; Bennejean, C.; Delagrange, P.; Boutin, J.; Lesieur, D. 5-halobenzothiophene analogues of melatonin: synthesis and affinity for MT1 and MT2 receptors in man. Pharm. Pharmacol. Commun. (2000), 6(2), 61-65. CODEN: PPCOFN ISSN:1460-8081. CAN 133:17342 AN 2000:258120 CAPLUS Antonini, Ippolito; Polucci, Paolo; Martelli, Sante. Pyrimido[4,5,6-kl]acridines. Synthesis, in vitro cytotoxicity and structure-activity relationships. Anti Cancer Drug Des. (1999), 14(5), 451-459. CODEN: ACDDEA ISSN:0266-9536. CAN 133:260 AN 2000:228542 CAPLUS

A Special Thank You To: Information Resources/Groton



Chih-Wu Chang



Fu-Ning Fung Information Resources/Ann Arbor



Judy Johnson Philipsen



Hai Mi Information Resources/UK



Sandra Wood



David Wood Information Resources/Japan



Toshihide Kokura ICS HelpDesk/Groton



Peirette Woodward



Joe Caputo



Susan Carey



Chris Thiry